Valeritas Holdings Inc. (VLRX)

1.27
NASDAQ : Health Technology
Prev Close 1.22
Day Low/High 1.10 / 1.30
52 Wk Low/High 1.22 / 27.87
Avg Volume 356.00K
Exchange NASDAQ
Shares Outstanding 7.16M
Market Cap 8.73M
EPS -34.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Valeritas Presents Positive H-Patch™ CBD Study Data At CannMed Conference

Valeritas Presents Positive H-Patch™ CBD Study Data At CannMed Conference

Study Shows Peak CBD Plasma Levels Obtained Using 7.5 Times Less CBD Compared to Oral Dosing

Clinical Trial Evaluating Delivery Of Regular Human Insulin Vs. Rapid Acting Insulin Delivered By Valeritas' V-Go® Meets Primary A1c Endpoint

Clinical Trial Evaluating Delivery Of Regular Human Insulin Vs. Rapid Acting Insulin Delivered By Valeritas' V-Go® Meets Primary A1c Endpoint

Use of Regular Human Insulin could save U.S. patients with type 2 diabetes and healthcare systems thousands of dollars per patient annually

Valeritas Announces Second Quarter 2019 Financial Results

Valeritas Announces Second Quarter 2019 Financial Results

Year-Over-Year Volume Growth in Target Accounts Grew 36%

Preclinical Study Shows Valeritas Proprietary H-Patch™ Wearable Delivery Device An Effective Option For Continuous Infusion Of Apomorphine

Preclinical Study Shows Valeritas Proprietary H-Patch™ Wearable Delivery Device An Effective Option For Continuous Infusion Of Apomorphine

- Parkinson's Disease Therapeutic Apomorphine Delivery via the h-Patch™ Offers Advantages Over  Subcutaneous Injections and Bulky Belt-worn Pump Devices - - Company Plans to Explore Partnering Opportunities with Apomorphine Therapeutics Companies - ...

Cannabidiol (CBD) Effectively Delivered Subcutaneously With Valeritas Proprietary H-Patch™ Wearable Device In Preclinical Study

Cannabidiol (CBD) Effectively Delivered Subcutaneously With Valeritas Proprietary H-Patch™ Wearable Device In Preclinical Study

- Company Plans to Explore Partnering Opportunities with CBD Therapeutics Companies -  - Company to Host a Conference Call Today, July 30, 2019 at 11:00 AM ET - BRIDGEWATER, N.

Valeritas Reports Fourth Quarter And Full Year 2017 Financial Results

Valeritas Reports Fourth Quarter And Full Year 2017 Financial Results

Company Will Host a Conference Call and Webcast Today, February 26, at 4:30 PM ET

Valeritas Reports Third Quarter 2017 Financial Results

Valeritas Reports Third Quarter 2017 Financial Results

Company Will Host a Conference Call and Webcast Today, November 8, at 4:30 PM ET

TheStreet Quant Rating: E+ (Sell)